Titan America SA Common Shares (TTAM)
16.04
+0.78 (5.11%)
NYSE · Last Trade: Nov 25th, 5:37 PM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025
